MetLife Investment Management, LLC - DECIPHERA PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$346,238
-9.7%
27,2200.0%0.00%0.0%
Q2 2023$383,258
-8.9%
27,2200.0%0.00%0.0%
Q1 2023$420,549
+9.3%
27,220
+16.0%
0.00%0.0%
Q4 2022$384,641
-11.4%
23,4680.0%0.00%
-25.0%
Q3 2022$434,158
+40.7%
23,4680.0%0.00%
+33.3%
Q2 2022$308,604
+41.9%
23,4680.0%0.00%
+200.0%
Q1 2022$217,548
+47.1%
23,468
+55.0%
0.00%0.0%
Q4 2021$147,918
-71.2%
15,1400.0%0.00%
-80.0%
Q3 2021$514,457
-7.2%
15,1400.0%0.01%0.0%
Q2 2021$554,275
-18.4%
15,1400.0%0.01%
-16.7%
Q1 2021$678,878
-21.4%
15,1400.0%0.01%
-33.3%
Q4 2020$864,040
+1.5%
15,140
-8.8%
0.01%0.0%
Q3 2020$851,477
-14.1%
16,5980.0%0.01%
-18.2%
Q2 2020$991,233
+176.0%
16,598
+90.3%
0.01%
+120.0%
Q1 2020$359,085
-33.9%
8,7220.0%0.01%
-16.7%
Q4 2019$542,857
+111.5%
8,722
+15.3%
0.01%
+100.0%
Q3 2019$256,688
+69.3%
7,563
+93.1%
0.00%
+50.0%
Q3 2018$151,628–3,916–0.00%–
 Download
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders